|
|
|
·¹½ºÄÝĸ½¶40mg(Ç÷ç¹Ù½ºÅ¸Æ¾³ªÆ®·ý) Lescol Cap. 40mg
|
Àü¹®ÀǾàÇ° | »èÁ¦ | ½Å¾à
|
|
¼öÀÔÀǾàÇ°
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
ȸ¹é»ö-Ȳ»öÀÇ °¡·ç¸¦ ÇÔÀ¯ÇÑ »ó : Àû°¥»ö, ÇÏ : ÁÖȲ»öÀÇ °æÁúĸ½¶Á¦ |
|
|
|
|
Á¦Á¶È¸»ç |
Novartis
|
ÆǸÅȸ»ç |
Çѱ¹³ë¹ÙƼ½º(ÁÖ)
|
Çã°¡Á¤º¸ |
ÃëÇÏ
(2022.12.26)
|
BIT ¾àÈ¿ºÐ·ù |
°íÁöÇ÷Áõ Ä¡·áÁ¦ (Antilipidemic Agents)
|
º¹ÁöºÎºÐ·ù |
218[µ¿¸Æ°æÈ¿ëÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
653600310[E01630131] Àú°¡¾à ´ëü Àμ¾Æ¼ºê Áö±Þ ´ë»ó \0 ¿ø/1ĸ½¶(2022.11.01)(ÇöÀç¾à°¡)\623 ¿ø/1ĸ½¶(2018.02.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Fluvastatin / C10AA04 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
°ÖÈÀüºÐ,
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
»êÈƼź,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
Àû»ö»êÈö,
Á©¶óƾ,
ź»ê¼ö¼Ò³ªÆ®·ý,
ź»êÄ®½·,
ÅÅÅ©,
Ȳ»ö»êÈö
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
ºÎÀÛ¿ëºóµµ ¹× ´ëó¹ý |
[À¯·á] |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-12-05 |
|
|
|
|
|
|
|
|